← All companies

CAH

Cardinal Health, Inc.

CAH NYSE Wholesale-Drugs, Proprietaries & Druggists' Sundries EDGAR ↗

$235.60

+8.53 +3.76%

Key statistics

from XBRL data in SEC filings

Market cap

$55.4B

Revenue (TTM)

$245B

Net income (TTM)

$1.66B

EPS (TTM)

$6.45

P/E ratio

36.5

Dividend yield

0.86%

Free cash flow

$1.85B

Cash

$2.78B

Total assets

$58.1B

Gross margin

3.7%

52-week range

$137.75 – $243.21

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2026 8-K Director or officer change; Regulation FD disclosure Mar 23, 2026 8-K Director or officer change Mar 5, 2026 10-Q Quarter ended 2025-12-31 Feb 5, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 5, 2026 8-K Regulation FD disclosure Jan 13, 2026 8-K Shareholder vote results Nov 6, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 30, 2025 8-K Entered a material agreement Oct 10, 2025 8-K Entered a material agreement Oct 3, 2025 8-K Entered a material agreement; Took on a direct financial obligation Aug 27, 2025 8-K Other events Aug 14, 2025 10-K Fiscal year ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Regulation FD disclosure Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 1, 2025 8-K Director or officer change; Regulation FD disclosure Mar 10, 2025 10-Q Quarter ended 2024-12-31 Jan 30, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 30, 2025 8-K Regulation FD disclosure Jan 14, 2025 8-K Entered a material agreement; Took on a direct financial obligation Dec 9, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Nov 22, 2024 8-K Other events Nov 18, 2024 8-K Entered a material agreement; Regulation FD disclosure Nov 12, 2024 8-K Shareholder vote results Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 1, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 1, 2024 8-K Entered a material agreement; Took on a direct financial obligation Oct 10, 2024 8-K Director or officer change Sep 9, 2024 10-K Fiscal year ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 2, 2024 8-K Regulation FD disclosure Apr 23, 2024 8-K Regulation FD disclosure Apr 22, 2024 8-K Director or officer change; Regulation FD disclosure Feb 28, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events Feb 20, 2024